AstraZeneca PLC (AZN.L) LSE
Currency In GBp
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 287.6B |
| Enterprise Value | 311.51B |
| P/E Ratio | 25.12 |
| PEG Ratio | 0.76 |
| Price/Sales Ratio | 4.32 |
| Price/Book Ratio | 5.54 |
| Enterprise/Revenue | 4.75 |
| Enterprise/EBITDA | 14.07 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.17 |
| Operating Margin | 0.24 |
AD
Management Effectiveness
| Return On Assets | 0.09 |
| Return On Equity | 0.22 |
Income Statement
| Revenue | 58.74B |
| Revenue/Share | 39.27 |
| Gross Profit | 48.11B |
| EBITDA | 19.83B |
| Net Income | 10.23B |
| Diluted EPS | 6.54 |
Balance Sheet
| Total Cash | 7.68B |
| Total Cash/Share | 4.95 |
| Total Debt | 33.92B |
| Total Debt/Equity | 0.72 |
| Current Ratio | 0.91 |
| Book Value Per Share | 30.59 |
Price History
| 52-Week Change | 18.68 |
| 52-Week High | 15,732 |
| 52-Week Low | 10,178 |
| Moving Average 50 Days | 13,704.36 |
| Moving Average 200 Days | 13,868.1 |
Statistics
| Average Volume | 2.21M |
| Shares Outstanding | 1.55B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 3.16 |
| Trailing Annual Dividend Yield | 1.87 |
| Payout Ratio | 0.47 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
